{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:32:46Z","timestamp":1786433566244,"version":"build-2736575974"},"reference-count":3,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.dsx.2026.103418","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:22:30Z","timestamp":1775690550000},"page":"103418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on \u201cEffects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study\u201d"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0059-1387","authenticated-orcid":false,"given":"S.","family":"Dhanya Dedeepya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8623-7919","authenticated-orcid":false,"given":"Vaishali","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6016-1241","authenticated-orcid":false,"given":"Nivedita Nikhil","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dsx.2026.103418_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2025.103312","article-title":"Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: a 44-week open label prospective study","volume":"19","author":"Seijas-Amigo","year":"2025","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"2","key":"10.1016\/j.dsx.2026.103418_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3803\/EnM.2020.35.2.217","article-title":"Effects of cardiovascular risk factor variability on health outcomes","volume":"35","author":"Lee","year":"2020","journal-title":"Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.dsx.2026.103418_bib3","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1001\/jama.287.23.3130","article-title":"Estimating treatment effects from observational data","volume":"287","author":"Michels","year":"2002","journal-title":"JAMA"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:26:38Z","timestamp":1786433198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402126000457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":3,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1871402126000457"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103418","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cEffects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study\u201d","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103418"}}